Track Jupiter Life Line Hospitals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 3.38 %
Low
236.8
High
292.0
1 Month returns: -10.66 %
Low
234.9
High
292.0
1 Year returns: -21.90 %
Low
230.4
High
340.0
3 Year CAGR: 5.92 %
Low
195.4
High
354.0
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Jupiter Life Line Hospitals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Jupiter Life Line Hospitals Ltd. Shareholding Pattern
Quarterly breakdown of Jupiter Life Line Hospitals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Jupiter Life Line Hospitals Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Jupiter Life Line Hospitals Ltd.?
The current share price of Jupiter Life Line Hospitals Ltd. is ₹ 244.80 as of 22 Oct 2026.
What is the market capitalisation of Jupiter Life Line Hospitals Ltd.?
The market capitalisation of Jupiter Life Line Hospitals Ltd. stands at ₹ 8,025.28 Cr.
What is the PE ratio of Jupiter Life Line Hospitals Ltd.?
The Price-to-Earnings (PE) ratio of Jupiter Life Line Hospitals Ltd. is 42.78 as of the latest trailing twelve months data.
What is the ROE and ROCE of Jupiter Life Line Hospitals Ltd.?
Jupiter Life Line Hospitals Ltd. has a Return on Equity (ROE) of 13.38% and a Return on Capital Employed (ROCE) of 13.18% as per the latest financial reports.
What is the 52-week high and low of Jupiter Life Line Hospitals Ltd.?
The 52-week high of Jupiter Life Line Hospitals Ltd. is - and the 52-week low is -.
What is the dividend yield of Jupiter Life Line Hospitals Ltd.?
The dividend yield of Jupiter Life Line Hospitals Ltd. is 0.08% based on the current market price.
What is the FII and DII holding in Jupiter Life Line Hospitals Ltd.?
Foreign Institutional Investors (FII) hold 9.13%, Domestic Institutional Investors (DII) hold 15.55% and retail/public investors hold 28.36% of Jupiter Life Line Hospitals Ltd. shares.
What sector does Jupiter Life Line Hospitals Ltd. belong to?
Jupiter Life Line Hospitals Ltd. operates in the Healthcare sector. 60% of analysts have a Buy or Strong Buy rating on Jupiter Life Line Hospitals Ltd. with a consensus target price of ₹ 345.00, implying 40.93% upside from current levels.
What is the beta of Jupiter Life Line Hospitals Ltd.?
The beta of Jupiter Life Line Hospitals Ltd. is 0.22, indicating its price volatility relative to the broader market. Over the past 1 year, Jupiter Life Line Hospitals Ltd. has delivered an absolute return of -19.87%.
What is the RSI of Jupiter Life Line Hospitals Ltd.?
The 14-day Relative Strength Index (RSI) of Jupiter Life Line Hospitals Ltd. is 38.14, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Jupiter Life Line Hospitals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Not enough talking points with positive stance
Negative
Expensive and at same valuation levels as industry median P/E
PE TTM of 42.78 indicates that the stock is expensive on a standalone basis. Discount to industry median P/E is modest at -1.9%
What is P/E Ratio?
Median: 43.61
Value 42.78
8.721546.82
Analysts have been downgrading forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has decreased by -7.75% in the last 3 months, indicating weak earnings momentum
What is Earnings upgrade (3M)?
Low dividend yield
The company has a low dividend yield of 0.08%
What is Dividend yield?
Neutral
Company's earnings are of moderate quality
Earnings quality score of 55.8 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
55.8 / 100
No red flags found!
No significant red flags found in the stock.
Sep 2014
Sep 2015
Sep 2016
Sep 2017
Sep 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Promoter
49.39
14.51
14.51
15.46
15.97
15.97
15.97
15.97
15.97
40.91
40.91
40.91
40.91
40.91
40.91
40.91
40.91
40.91
40.91
40.91
40.91
40.91
Indian Promoter
49.39
14.51
14.51
15.46
15.97
15.97
15.97
15.97
15.97
40.91
40.91
40.91
40.91
40.91
40.91
40.91
40.91
40.91
40.91
40.91
40.91
40.91
Foreign Promoter
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
17.31
17.90
18.33
19.91
22.29
22.37
22.25
22.17
22.60
22.49
22.07
22.47
24.84
Mutual Funds / UTI
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
11.57
12.68
13.28
12.81
12.34
11.33
11.09
11.05
10.99
11.55
10.97
10.89
13.45
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.76
0.90
0.54
0.72
0.91
0.79
0.94
1.14
2.36
2.30
2.45
2.01
2.10
Govt
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
4.62
3.96
4.17
6.06
8.84
10.04
10.04
9.77
9.06
8.48
8.48
9.37
9.13
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.36
0.34
0.34
0.32
0.21
0.21
0.19
0.21
0.20
0.17
0.17
0.19
0.16
Non-Institution
50.61
85.49
85.49
84.54
84.03
84.03
84.03
84.03
84.03
41.78
41.19
40.75
39.17
36.79
36.72
36.84
36.92
36.50
36.59
37.02
36.62
34.25
Bodies Corporate
0.00
38.77
38.77
38.34
38.90
38.90
38.90
38.90
38.90
5.76
5.71
5.66
5.73
5.71
5.70
5.71
5.74
5.74
5.82
6.07
6.01
5.89
Others (incl. Retail)
No. of shareholders
50.61
0
46.72
0
46.72
0
46.20
0
45.13
0
45.13
0
45.13
0
45.13
0
45.13
0
36.02
54,679
35.48
39,251
35.09
34,997
33.44
35,668
31.08
33,937
31.02
33,764
31.13
33,790
31.18
34,022
30.76
34,181
30.77
33,444
30.95
32,814
30.61
33,024
28.36
33,079
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Holdings and Presence
Indices and prominent investors with a stake in this stock.
History of Jupiter Life Line Hospitals Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.
Stock Split1 : 5
Ex-date: 24th Jul 2026Announced on: 16th May 2026
Nominal Value changes from INR 10 to INR 2.
Dividend₹ 1/share
Record date: 22nd May 2026Ex-date: 22nd May 2026
Announced on: 11th May 2026
Dividend₹ 1/share
Record date: 4th Jul 2025Ex-date: 4th Jul 2025
Announced on: 9th May 2025
Dividend₹ 1/share
Record date: 2nd Aug 2024Ex-date: 2nd Aug 2024
Announced on: 10th May 2024
Company Profile
Overview of Jupiter Life Line Hospitals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Jupiter Life Line Hospitals Limited is a provider of advanced multi-specialty quaternary healthcare. Its services include cardiology, oncology, dermatology, gastroenterology, orthopedics, infectious diseases, nephrology, nutrition and dietetics, neurology and neurosciences, pediatrics, organ transplant, hematology, rheumatology, urology, endocrinology and diabetes, and ophthalmology. It offers 30+ clinical specialties, supported by cutting-edge diagnostics, specialized surgical capabilities, and dedicated critical care infrastructure. It offers medical technologies to support complex procedures and minimally invasive treatments, such as robotic-assisted surgical systems, interventional radiology capabilities, hematology and bone marrow transplant unit, integrated diagnostic imaging and laboratory services, and comprehensive rehabilitation services. Its technologies include sleep labs and cognitive rehabilitation systems and endoscopic ultrasound and endobronchial ultrasound.
Jupiter Life Line Hospitals Limited is a provider of advanced multi-specialty quaternary healthcare. Its services include cardiology, oncology, dermatology, gastroenterology, orthopedics, infectious diseases, nephrology, nutrition and dietetics, neurology and neurosciences, pediatrics, organ transpl...